Preprint · Jan 21, 2026

Developing a multicomponent nturitional supplement to enhance cognitive function in older adults-- a precision biomarker analysis

By Gerber S, Roberts SB, Ottaviani J et al.

A 12-month randomized, placebo-controlled pilot trial in n=24 adults aged ≥55 years was designed to test whether a portable, easy-to-mix multi-component nutritional supplement (MCNS) can be delivered in a way that supports sustained daily intake in a population at risk for cognitive decline. The intervention prioritizes real-world feasibility (palatability, convenience, accessibility) and verifies exposure using complementary adherence measures and objective biomarkers over multiple time points, including red blood cell omega-3 fatty acids and targeted urinary metabolites that reflect intake and metabolism of the bioactive components. Food composition analysis of the MCNS was done to quantify total and specific polyphenols, as well as total and sepcific fatty acids which are compared to biomarker concentrations at 0, 3, 6, and 12 months of daily exposure to demonstrate adherence, and explore preliminary absorption mechanics. Verified biological exposure is a prerequisite for detecting treatment-related changes in neurocognitive trajectories and can be used to interpret outcome changes in cognitive test metrics (for example, memory, executive function, processing speed) as a function of measured exposure, to distinguish non-response from non-adherence, and to support future precision-oriented analyses that account for baseline status and inter-individual metabolic variability.

doi.org/10.17605/osf.io/mt6gbOpen accessInterventions

AgingResearch.News